NEW YORK, April 26, 2017 /PRNewswire/ -- Spheryx, Inc. will be demonstrating their new instrument, xSight, which is based on their proprietary technology, Total Holographic Characterization®, at PEGS Boston from May 1-4, 2017 in the Exhibit Hall at the Seaport World Trade Center. PEGS Boston is a weeklong event that draws an international delegation of nearly 2,200 participants interested in collaborating and sharing best practices in the areas of protein and antibody engineering, oncology, expression, analysis, immunogenicity, and therapeutics. xSight is able to detect and characterize protein aggregates, a known safety hazard in biologic pharmaceuticals, using technology based on holographic video microscopy. Dr. David Ruffner, Spheryx Vice President of Research and Development, will also be making a presentation at the conference entitled "Protein Aggregate and Contaminant Detection: Total Holographic Characterization®". Dr. Laura Philips, President and CEO of Spheryx, stated, "PEGS Boston is a great venue to introduce xSight to the biologic pharmaceutical community. xSight is a powerful tool for monitoring protein aggregates as well as other contaminants such as silicone oil that are encountered in the development and manufacturing of protein-based pharmaceuticals."
About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company providing Total Holographic Characterization® of colloidal materials Spheryx's proprietary technology uses holographic video microscopy to characterize each particle in colloidal dispersions and multi-component colloidal mixtures, offering unprecedented insights into these materials' characteristics. Applications include R&D, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs. For more information: https://www.spheryx.solutions/
Note: This news release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially.
Laura Philips, CEO
SOURCE Spheryx, Inc.